Medical News Today News Alert

Dear Subscriber,

Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories. To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .

Arthritis / Rheumatology News
REALISTIC: Certzolimab Delivers In Real World Situations After 12 weeks of treatment certolizumab pegol (Cimzia ®) delivered rapid and consistent improvements in a broad range of rheumatoid arthritis (RA) patients regardless of whether or not they had received prior TNF inhibitors, concluded the latest analysis of the Phase III b REALISTIC trial.	28 May 2011
Data Presented At Two Global Medical Congresses Reinforce Benefit Of Enbrel® (etanercept) For Patients With Chronic Inflammatory Conditions Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) announced new results from multiple studies of ENBREL, further expanding the body of evidence supporting the efficacy and safety profile of ENBREL, the most prescribed biologic by rheumatologists in the United States (U.	28 May 2011
RoActemra Could Change The Current Standard Of Treatment For People Living With Rheumatoid Arthritis Roche announced new data from the ACT-RAY study, presented at the European League Against Rheumatism congress. The results demonstrated that in people with rheumatoid arthritis (RA), RoACTEMRA (tocilizumab, known as ACTEMRA outside Europe) alone had comparable clinical efficacy to RoACTEMRA plus methotrexate (MTX).	28 May 2011
New Data For Cimzia® (Certolizumab Pegol) Showed A Rapid Clinical Response Across A Broad Population Of Rheumatoid Arthritis (RA) Patients UCB announced data which showed that the addition of Cimzia® (certolizumab pegol) to current therapy was associated with a rapid and consistent clinical response in a diverse group of rheumatoid arthritis (RA) patients.	28 May 2011

Flu / Cold / SARS News
Flu Vaccines Will Be Enough For Half The Population - So Who Should Get Them? While the CDC is advising everyone to get a flu shot, vaccine makers say this is not necessarily true - some people may not need a repeat shot. Whoever is right, even with record production for this coming fall, only half the US population will be able to get vaccinated.	28 May 2011

Heart Disease News
Combination Niacin Does Not Improve Heart Attack And Stroke Risk Niacin, also known as vitamin B3, when combined with statin only therapy for patients with heart and vascular disease does not lower heart attack and stroke risk - a finding which made the National Heart, Lung, and Blood Institute and Abbott Laboratories end a clinical trial 18 months early.	28 May 2011
Boston Scientific Announces Voluntary Recall Of ICross™ Coronary Imaging Catheters Boston Scientific Corporation (NYSE: BSX) announced that it is voluntarily recalling all of its iCross™ Coronary Imaging Catheters used in intravascular ultrasound (IVUS) imaging in patients who are candidates for transluminal coronary interventional procedures.	28 May 2011

You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .